Latest filing published 16 Jun 2022 for Cyclacel Pharmaceuticals, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Lloyd Sems, listed as board member, appears in our data through filings on Bio Green Med Solution, Inc. shares, published by SEC (Form 4). We count 2 filings; the first trade dates from 15 June 2021 and the latest from 14 June 2022.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 16 June 2022 with a share grant in Bio Green Med Solution, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations